13 of 113 unique stocks in common · Jaccard: 11.5%
A weighted portfolio overlap of 20.15% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹20.15 is allocated to the exact same companies at the same relative proportions. The schemes share 13 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 7.83% in UTI Nifty 50 Index Fund and 4.65% in UTI Nifty India Manufacturing Index Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in UTI Nifty 50 | in UTI Nifty India |
|---|---|---|
| Reliance IndustriesPetroleum Products | 7.83% | 4.65% |
| Mahindra & MahindraAutomobiles | 2.66% | 5.13% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.91% | 4.86% |
| Maruti Suzuki IndiaAutomobiles | 1.60% | 4.08% |
| Tata SteelFerrous Metals | 1.38% | 3.52% |
| Bharat ElectronicsAerospace & Defense | 1.35% | 3.43% |
| Hindalco IndustriesNon - Ferrous Metals | 1.33% | 3.40% |
| Bajaj AutoAutomobiles | 1.22% | 3.10% |
| JSW SteelFerrous Metals | 1.11% | 2.84% |
| Eicher MotorsAutomobiles | 0.99% | 2.53% |
| CiplaPharmaceuticals & Biotechnology | 0.72% | 1.83% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.64% | 1.63% |
| Tata Motors Passenger VehiclesAutomobiles | 0.59% | 1.49% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.